UK Votes To Leave The EU – Where Next For The Life Sciences?
UK vote to leave the EU opens the prospect of years of negotiations over the union's future relationship with one of its most valued member states.
You may also be interested in...
J&J's head of scientific strategy and policy says in an interview that the two-year withdrawal timeline for the UK to leave the EU 'hopefully' provides the firm 'enough time to ensure continuity of business.'
Commissioner says his agency does not have a plan to deal with UK's departure from the EU.
Brexit vote creates uncertainty about biopharma policies in the UK and how local companies interact with the rest of the world;; antibiotic use decreases in several countries; high prices prompt European Commission review of industry incentives.